LIMK2 and colorectal carcinoma: These findings indicated that imbalanced expression of LIMK1 and LIMK2 occurred as CRC progressed and showed that LIMK1 and LIMK2 made a joint contribution to enhancing CRC cell metastasis via the Wnt/β-catenin pathway.